Evidence map›Paper›PMID 20333208›Full record

ArticleGenome biology and evolution2009

The evolution of reduced microbial killing.

Jan A C Vriezen, Michael Valliere, Margaret A Riley

Open access · goldAbstract read
In one paragraph

Article in Genome biology and evolution, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Frontiers in microbiology · 2021
    Article
  5. Article
  6. Anti-infective properties of bacteriocins: an update.Cellular and molecular life sciences : CMLS · 2013
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jan A C VriezenDepartment of Biology, University of Massachusetts, MA, USA. cvriezen@bio.umass.edu
Michael Valliere
Margaret A Riley
University of Massachusetts Boston · US

Funding

Evolution of Stress-Induced Bacterial ToxinsR01AI064588 · NIAID · UNIVERSITY OF MASSACHUSETTS AMHERST · PI RILEY, MARGARET A. · 2007 to 2010
$1.5M
Evolution of Antibiotic Resistance in Enteric BacteriaR01GM068657 · NIGMS · UNIVERSITY OF MASSACHUSETTS AMHERST · PI RILEY, MARGARET A. · 2005 to 2009
$1.5M
NIAID NIH HHS R01 AI064588NIGMS NIH HHS R01 GM068657
6 · The paper itself

Abstract

Bacteria engage in a never-ending arms race in which they compete for limited resources and niche space. The outcome of this intense interaction is the evolution of a powerful arsenal of biological weapons. Perhaps the most studied of these are colicins, plasmid-based toxins produced by and active against Escherichia coli. The present study was designed to explore the molecular responses of a colicin-producing strain during serial transfer evolution. What evolutionary changes occur when colicins are produced with no target present? Can killing ability be maintained in the absence of a target? To address these, and other, questions, colicinogenic strains and a noncolicinogenic ancestor were evolved for 253 generations. Samples were taken throughout the experiment and tested for killing ability. By the 38th transfer, a decreased killing ability and an increase in fitness were observed in the colicin-producing strains. Surprisingly, DNA sequence determination of the colicin plasmids revealed no changes in plasmid sequences. However, a set of chromosomally encoded loci experienced changes in gene expression that were positively associated with the reduction in killing. The most significant expression changes were observed in DNA repair genes (which were downregulated in the evolved strains), Mg ion uptake genes (which were upregulated), and late prophage genes (which were upregulated). These results indicate a fine-tuned response to the evolutionary pressures of colicin production, with far more genes involved than had been anticipated.

Indexed as

colicinogenyDNA repairEscherichia coliprophageserial transfertranscriptional profiling

Identifiers

PMID20333208
PMCPMC2817434
OpenAlexW2132547260

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.